As of  November 2019 all 71 of New Jersey’s acute-care hospitals were connected to and sharing data with the statewide New Jersey Health Information Network (NJHIN), either directly or through their regional Healthcare Information Exchange …

A healthcare provider, health information network, health information exchange or a health IT developer can be an actor of information blocking. Information blocking is any activity that interferes with or limits access, exchange, or use …

Local municipalities and communities are addressing an unprecedented number of challenges due to unrest, conflict and anxiety created by the COVID-19 pandemic, political turmoil and economic slowdown. The impact of these current crises will persist …

Today’s advanced manufacturers are facing an escalating skills gap in their work force. For many, older employees are reaching retirement age in large numbers and there is a shortage of skilled employees to fill their shoes. Technical high schools and community …

The New Jersey Innovation Institute (NJII) has partnered in a Joint Venture with ViRvii, Inc., a proprietary Virtual Reality (VR) and Augmented Reality (AR) technology and platform provider to become the leader in professional workforce …

Like all businesses, U.S. based advanced manufacturers are facing a brave new world as a result of COVID -19.  Unanticipated disruption to their supply chains, workforce uncertainty and entirely new cost versus risk models are causing local manufacturers to re-think and re-assess their …

All 71 hospitals in New Jersey contribute information about patient admissions, discharges and transfers to the New Jersey Health Information Network (NJHIN). In the midst of the COVID-19 pandemic they all recognize the importance of …

The New Jersey Innovation Institute (NJII) has partnered with education technology provider Castle Point Learning Systems (CPLS) to expand the latter’s groundbreaking online mathematics learning platform, Gradarius™. Gradarius offers interactive, customizable instruction in all levels of mathematics, from basic math and …

The New Jersey Innovation Institute’s Biopharma Division, which includes BioCentriq, its cell and gene therapy development and manufacturing center, has welcomed Beth Thompson-Webb to its advisory committee.  Thompson-Webb has more than two decades of experience in life sciences …

Dr. Haro Hartounian is senior vice president and general manager of the Biopharma Division of the New Jersey Innovation Institute (NJII). The division, founded in 2015, includes a state-of-the-art cell and gene therapy development center …